Keep your Peptide Programmes on track

LliDeillllQ

Drug Product

oo Long Peptides ^

• • ^ l ^ O i ^ H ^ B ^ H i O ^ B ^ ^ ^ ^ ' ^ ^ 3 ^ ^ " ^ ^ ^ ^ Chemokines

^ Defensins V

Analysis l ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ l μ. Isotope ^T ^~

Solid Phase < % Formulation I Liquid Phase

Stability à / L J \ J r . . [: H Fluorescent Biotin

Conjugation cytotoxic JB

•

mg to kg I m Cytokines API Manufacture

ê;; • Drug Product — · —

Conjugation #

Long Peptides #

Labelling -:- *

ALMAC '"*""* i-or American mqmties

REQUESTM0REATADINF0N0W.ORG